Quick Answer
SELLAS Life Sciences Group, Inc. reported R&D Expense of $15.67 million for fiscal year 2021.
SELLAS Life Sciences Group, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2021 | $15.67M | +68.9% |
| 2020 | $9.28M | +27.4% |
| 2019 | $7.29M | -16.9% |
| 2018 | $8.77M | +44.5% |
| 2017 | $6.07M | -46.8% |
| 2016 | $11.39M | -22.0% |
| 2012 | $14.61M | +279.5% |
| 2011 | $3.85M | -51.1% |
| 2010 | $7.87M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $4.54M | +91.8% | +31.4% |
| June 30, 2021 | $3.46M | +51.6% | -19.3% |
| March 31, 2021 | $4.28M | +129.8% | +81.0% |
| September 30, 2020 | $2.37M | +31.6% | +3.8% |
| June 30, 2020 | $2.28M | +65.1% | +22.3% |
| March 31, 2020 | $1.86M | +0.3% | +3.6% |
| September 30, 2019 | $1.80M | +4.6% | +30.3% |
| June 30, 2019 | $1.38M | -13.3% | -25.7% |
- SELLAS Life Sciences Group, Inc. showed an increase of +68.9% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2021 period, SELLAS Life Sciences Group, Inc.’s r&d expense has grown by 99.1% (from $7.87 million to $15.67 million).
- The most recent figure is from SELLAS Life Sciences Group, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 31, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: